MedTrace Logo

Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells

NCT04397354 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2023-01-04

No results posted yet for this study

Summary

The protection of cochlear cells is one of the main concerns of cochlear implant surgery. New electrode designs or additional molecules have been used for this purpose. The aim of the study is to test the effect of dexamethasone in two different application methods.

Conditions

  • Hearing Loss, Sensorineural

Interventions

DRUG

Intracochlear Dexamethasone

intracochlear injection of dexamethasone with cochlear implantation

DRUG

Intratympanic Dexamethasone

intratympanic injection of dexamethasone with cochlear implantation

DRUG

No additional drugs(control Group)

Control group: No drugs will be injected middle ear with cochlear implantation

Sponsors & Collaborators

  • Pamukkale University

    lead OTHER

Principal Investigators

  • Fazil N Ardic, MD · Pamukkale University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-02
Primary Completion
2022-08-01
Completion
2022-09-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04397354 on ClinicalTrials.gov